Bixiye
QP59-19 eviCore Group Number List to be Removed
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Natiijooyinka Raadinta
Soo bandhiga 2721 - 2730 ee natiijooyinka 5384
Bixiye
QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP20R1-20 Update: Medical Drug Update for Teprotumumab (Tepezza)
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP46-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP45-20 Preventive Care Provided Via Telehealth
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP43-20 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Valrox)
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP44-20 Non-Covered Medicare Services and Organization Determination Reminder for Platinum Blue and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
P29-20 Sequestration Suspension for Medicare Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P31-20 2020 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P38-20 Non-Emergency Medical Transportation Fee Schedule Update
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020